https://www.fool.com/investing/2024/01/29/why-beam-therapeutics-stock-zoomed-17-higher-today/?source=financialcontent&utm_source=financialcontent&utm_medium=feed&utm_campaign=article
JPMorgan Chase becomes the latest institution in the company's bull pen.
beam therapeuticsstockzoomedhighertoday
https://www.fool.com/investing/2023/10/31/why-beam-and-verve-therapeutics-stock-soared-while/
Lilly is putting its money where its mouth is with its purchase of cutting-edge medical technology.
verve therapeuticseli lillybeamshares
https://www.businesswire.com/news/home/20230112005081/en/Neutron-Therapeutics-Announces-Successful-Generation-of-a-Neutron-Beam-for-BNCT-at-Shonan-Kamakura-General-Hospital-in-Japan
Neutron Therapeutics (NT), a targeted radiation oncology therapy company developing a comprehensive clinical solution for Boron Neutron Capture Therapy (BNCT...
neutrontherapeuticsannouncessuccessfulgeneration
https://www.ux-architecture.com/beam-therapeutics
Our client for this office + lab fit-out asked for a space that matched their emergent culture: innovative, precise, collaborative, rigorous, and humble. They...
beam therapeutics
https://www.fool.com/investing/2023/10/30/reasons-why-beam-therapeutics-remains-risky-stock/
Shares of the gene-editing biotech might not have hit rock bottom yet.
beam therapeuticsreasonsremainsriskystock